In vivo DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme
Glioblastoma is an aggressive tumor with poor survival rates. Bispecific T cell engagers (BTEs) against different cancers are in various stages of clinical development. Toxicity resulting from cytokine release syndrome and the short half-life of BTEs, which necessitates continuous infusion, complica...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2022-09-01
|
| Serier: | Molecular Therapy: Oncolytics |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2372770522000924 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
